All articles tagged with #anti amyloid therapy
New anti-amyloid drugs for Alzheimer's show promise in slowing disease progression but come with significant risks like brain bleeds and high costs, leading to cautious optimism among neurologists about their use and effectiveness.
Researchers are testing a range of potential new therapies for Alzheimer's disease, including combination therapies that target different stages of the disease, anti-tau and anti-amyloid vaccines, and gene therapy. Trials of combination therapies are complex and costly, but researchers hope that sensitive new biomarkers will help to uncover more about the mechanisms of Alzheimer's. Most researchers think that treatment will need to be personalized, and individuals at different disease stages will need different therapies.